CTIC

CTI BioPharma Corp. (DE) Common Stock

Delisted

CTIC was delisted on the 23rd of June, 2023.

92 hedge funds and large institutions have $334M invested in CTI BioPharma Corp. (DE) Common Stock in 2022 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 24 increasing their positions, 18 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

33% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 18

22% more call options, than puts

Call options by funds: $3.15M | Put options by funds: $2.57M

Holders
92
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$3.15M
Puts
$2.57M
Net Calls
Net Calls Change

Top Buyers

1 +$19.9M
2 +$16.9M
3 +$9.21M
4
SI
Sofinnova Investments
California
+$9.12M
5
Two Sigma Investments
Two Sigma Investments
New York
+$6.84M

Top Sellers

1 -$19.2M
2 -$8.8M
3 -$5.55M
4
Renaissance Technologies
Renaissance Technologies
New York
-$1.14M
5
Group One Trading
Group One Trading
Illinois
-$942K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$99.8M
2
$41.7M
3
$25.6M
4
$21.9M
5
$18M
6
$16.8M
7
$10.2M
8
$9.12M
9
$8.49M
10
$8.37M
11
$6.55M
12
$6.07M
13
$5.19M
14
$4.73M
15
$4.65M
16
$4.41M
17
$4.03M
18
$3.63M
19
$3.02M
20
$2.96M
21
$2.6M
22
$2.48M
23
$2.4M
24
$1.63M
25
$1.4M